Table 3.
Descriptive statistics showing the distribution of cardiac drug therapies and HADS-A
| HADS-A < 8 n = 6107 n (%) | HADS-A ≥ 8 n = 2891 n (%) | p values | |
|---|---|---|---|
| Diuretics | 3162 (52) | 1579 (55) | 0.012 |
| Lipid-lowering Agents | 4449 (73) | 2194 (76) | 0.002 |
| Aspirins | 4304 (70) | 2101 (73) | 0.032 |
| Anticoagulants | 5681 (93) | 2676 (93) | 0.43 |
| Aldosterone antagonists | 1158 (19) | 566 (20) | 0.48 |
| Nitrates | 2234 (37) | 1234 (43) | < 0.001 |
| Antiarrhythmics | 978 (16) | 514 (18) | 0.036 |
| Digoxin | 841 (14) | 416 (14) | 0.43 |
| Angiotensin receptor antagonists | 1436 (24) | 712 (25) | 0.25 |
| ACE-inhibitors | 2548 (42) | 1200 (42) | 0.85 |
| Beta-blockers | 4921 (81) | 2395 (83) | 0.010 |